» Articles » PMID: 34683082

Advances in Personalized Medicines Along with Functional Genomics and Pharmacogenomics

Overview
Journal J Pers Med
Date 2021 Oct 23
PMID 34683082
Authors
Affiliations
Soon will be listed here.
Abstract

State-of-the-art research on the human genome has produced remarkable research achievements in pharmacogenomics and functional genomics, and these research results are making an invaluable contribution to the advancement of personalized medicine [...].

References
1.
Hu R, Chuang C, Lin C, Su S, Chang L, Wu S . Effect of MACC1 Genetic Polymorphisms and Environmental Risk Factors in the Occurrence of Oral Squamous Cell Carcinoma. J Pers Med. 2021; 11(6). PMC: 8228283. DOI: 10.3390/jpm11060490. View

2.
Hsieh M, Lu H, Lin C, Lee C, Yang S, Wu P . Genetic Variants of lncRNA Are Associated with the Clinicopathologic Development of Oral Cancer. J Pers Med. 2021; 11(5). PMC: 8146215. DOI: 10.3390/jpm11050348. View

3.
Su S, Lin C, Ju P, Chang L, Chuang C, Liu Y . Association of LINC00673 Genetic Variants with Progression of Oral Cancer. J Pers Med. 2021; 11(6). PMC: 8227532. DOI: 10.3390/jpm11060468. View

4.
Hindi N, Alenbawi J, Nemer G . Pharmacogenomics Variability of Lipid-Lowering Therapies in Familial Hypercholesterolemia. J Pers Med. 2021; 11(9). PMC: 8468752. DOI: 10.3390/jpm11090877. View

5.
Blum K, Kazmi S, Modestino E, Downs B, Bagchi D, Baron D . A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration. J Pers Med. 2021; 11(3). PMC: 8002215. DOI: 10.3390/jpm11030212. View